Joe Verghese, M.B.B.S., M.S., an international leader in aging and cognition research at Albert Einstein College of Medicine and Montefiore Health System, has received two grants from the National Institutes of Health totaling $13.8 million to conduct studies on pre-dementia and Alzheimer’s disease.
The widespread use of antiretroviral therapy to suppress the HIV virus has helped tens of millions of people with HIV live healthier, longer lives—but an unfortunate consequence of people living longer with HIV is an increased risk of cancer. For 25 years, the AIDS Malignancy Consortium (AMC) has led national and international efforts to prevent and treat of HIV-related cancers. Now, Montefiore Health System and Albert Einstein College of Medicine have received a five-year, $111 million grant from the National Cancer Institute (NCI) to lead this research consortium.
The first study comparing the immune responses of adults and children with COVID-19 has detected key differences that may contribute to understanding why children usually have milder disease than adults. The findings also have important implications for vaccines and drugs being developed to curb COVID-19. The study was published today in Science Translational Medicine and was conducted by scientists at Albert Einstein College of Medicine, Children’s Hospital at Montefiore (CHAM), and Yale University.
Chemotherapy usually cures children diagnosed with acute lymphoblastic leukemia (ALL), but the treatment may hamper brain development and impact key cognitive functions including sensory processing, memory, and attention. Researchers at Albert Einstein College of Medicine, Children’s Hospital at Montefiore (CHAM), and Rutgers Cancer Institute of New Jersey have received a five-year, $4.6 million grant from the National Institutes of Health (NIH) to determine how chemotherapy exerts its damaging effects on the brain. Their long-term objective is to use this information to develop protective interventions that can prevent permanent harm.
A new study shows how chronic psychological stress leads to painful vessel-clogging episodes—the most common complication of sickle-cell disease (SCD) and a frequent cause of hospitalizations. The findings, made in mice, show that the gut microbiome plays a key role in triggering those episodes and reveals possible ways to prevent them. The research was conducted by scientists at Albert Einstein College of Medicine and published online today in Immunity.
Britta Will, Ph.D., assistant professor of medicine and of cell biology at Albert Einstein College of Medicine, has won a 2020 Pershing Square Sohn Prize for Young Investigators in Cancer Research. Dr. Will is one of seven New York City area-based scientists to receive the prestigious award, which provides $600,000 over three years for innovative basic science cancer research.
Earle Chambers, Ph.D., M.P.H., has been appointed director of the division of research in the department of family and social medicine at Albert Einstein College of Medicine and Montefiore Health System. In this role, Dr. Chambers will help determine the priorities and focus of the department’s research agenda and manage the resources available for the research faculty. He is currently an associate professor of family and social medicine and of epidemiology & population health, and a member of the leadership team for the New York Regional Center for Diabetes Translation Research at Einstein.
Albert Einstein College of Medicine has received a $9.5 million, five-year grant from the National Institutes of Health (NIH) to support the Einstein-Mount Sinai Diabetes Research Center (ES-DRC). The multi-institutional center is a leader in basic, translational, clinical, and community-based research and training in type 1 and type 2 diabetes, obesity, and other metabolic disorders.
Montefiore Health System and Albert Einstein College of Medicine have begun the next stage of the Adaptive COVID-19 Treatment Trial (ACTT), to evaluate treatment options for people hospitalized with severe COVID-19 infection. The new iteration of the trial, known as ACTT 2, is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
While most children infected with the novel coronavirus have mild symptoms, a subset requires hospitalization and a small number require intensive care. A new report from pediatric anesthesiologists, infectious disease specialists and pediatricians at the Children’s Hospital at Montefiore (CHAM) and Albert Einstein College of Medicine, describes the clinical characteristics and outcomes of children hospitalized with COVID-19, during the early days of the pandemic.
Montefiore Health System, Albert Einstein College of Medicine and NYU Langone have launched a new clinical trial to study if convalescent plasma—taken from people who have recovered from COVID-19—is effective in treating the disease.
Researchers at Montefiore Health System and Albert Einstein College of Medicine have begun testing the drug hydroxychloroquine for the treatment of COVID-19, as part of a nationwide trial sponsored by the National Heart, Lung, and Blood Institute (NHLBI).
Answering the call for additional medical workers to join the frontlines of the COVID-19 pandemic, today more than 100 medical students at Albert Einstein College of Medicine graduated a month early. Many of will immediately join the staff of hospitals in New York City.
Researchers at Montefiore Health System and Albert Einstein College of Medicine showed for the first time that men clear the novel coronavirus from their bodies slower than women and found a possible explanation: a potential male-only “reservoir” for coronavirus.
Montefiore Health System and Albert Einstein College of Medicine has joined a clinical trial to evaluate the experimental drug remdesivir to treat people who are hospitalized with severe COVID-19 infection.
Researchers at Albert Einstein College of Medicine secured $178 million from the National Institutes of Health in federal fiscal year 2019, marking the largest annual total in the institution’s history (excluding supplemental stimulus funding distributed as a part of the American Recovery and Reinvestment Act of 2009). Major grants included those to lead international consortiums to study Ebola and HIV, as well as those focusing on neuroscience, genetics, and improving health among minority groups.
Albert Einstein College of Medicine and the CUNY Graduate School of Public Health and Health Policy (CUNY SPH) announced an agreement today to offer Einstein medical students an opportunity to complete a five-year program resulting in a Doctor of Medicine (M.D.) degree from Einstein and a Master’s Degree in Public Health (M.P.H.) degree from CUNY SPH.
A study of New York City firefighters finds that exposure to 9/11 World Trade Center (WTC) dust is associated with an increased risk of cardiovascular disease (CVD). Researchers at Albert Einstein College of Medicine, Montefiore Health System, and the Fire Department of the City of New York (FDNY) report in JAMA Network Open that those who arrived first at the WTC site have a 44% increased risk of CVD compared to those who arrived later.
Members of Albert Einstein College of Medicine’s class of 2023 received monogrammed white coats and stethoscopes last week in a ceremony marked with pride and reminders of responsibility as they embark on their lifelong journey of medical education.
In a study published online today in Nature, researchers at Albert Einstein College of Medicine describe the first complete wiring diagram of the nervous system of an animal, the roundworm Caenorhabditis elegans, used by scientists worldwide as a model organism. The study includes adults of both sexes and reveals substantial differences between them.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right